Giardia lamblia Antibodies

Santa Cruz Biotechnology offers a broad range of Giardia lamblia monoclonal antibodies for research focused on understanding this important protozoan parasite. Giardia lamblia Antibodies are essential for various techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Giardia lamblia is a flagellated protozoan that causes giardiasis, a common intestinal infection in humans and animals. The parasite can lead to severe gastrointestinal symptoms and is frequently detected in contaminated water sources. Understanding the biology and pathology of Giardia lamblia is crucial for developing effective treatments and preventive measures against giardiasis. Research into Giardia lamblia continues to reveal new insights about its cellular structure, metabolism, and host-pathogen interactions. Advanced microscopy techniques combined with specific molecular markers have enhanced our understanding of the parasite's life cycle and infection mechanisms. Current studies focus on identifying potential therapeutic targets and developing improved diagnostic methods. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific knowledge about Giardia lamblia and contribute to developing better treatments for giardiasis.